Milton Werner

Principal investigator, leads Inhibikase Therapeutics, Inc..

BiotechFounder

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.

2017First federal award

$4.3MFederal grants as PI3 awards

0Patents grantedNone matched

0PapersOpenAlex

Career record

Federal awards and patents by year

20172018

AwardsPatents

Federal awards as principal investigator

3 awards · $4.3M

Date	Agency	Award	Amount	Company
Sep 17, 2018	NIH	SBIR Phase II Advanced Prodrug Treatment for CML	$2.0M	Inhibikase Therapeutics, Inc.
Sep 6, 2017	NIH	SBIR Phase I Prodrug treatment for CML	$285K	Inhibikase Therapeutics, Inc.
Mar 1, 2017	NIH	SBIR Phase II Advanced PML antiviral	$2.0M	Inhibikase Therapeutics, Inc.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#347

Awards as PI#822

Patents#273

From filings, awards and patents

Companies

Inhibikase Therapeutics, Inc.Leads (SEC Form D) · Biotech

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.